Xaira exec divulges R&D focus, how $1B fundraise fuels AI-driven hunt for what the ‘industry is hungriest for’ March 19, 2026
Boehringer pens $500M pact with British biotech for oral approach to autoimmune diseases February 26, 2026
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program February 26, 2026
